Oxygenta [OXYGENTAPH] vs Sun Pharmaceutical [SUNPHARMA] Detailed Stock Comparison

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Oxygenta wins in 6 metrics, Sun Pharmaceutical wins in 10 metrics, with 0 ties. Sun Pharmaceutical appears stronger overall.

View Metrics Details

Vital Metrics Comparison

MetricOxygentaSun PharmaceuticalBetter
P/E Ratio (TTM)444.3237.74Sun Pharmaceutical
Price-to-Book RatioN/A5.43N/A
Debt-to-Equity Ratio-2.433.26Oxygenta
PEG RatioN/A-1.94N/A
EV/EBITDA-28.1823.91Oxygenta
Profit Margin (TTM)-13.45%19.29%Sun Pharmaceutical
Operating Margin (TTM)-50.72%24.34%Sun Pharmaceutical
EBITDA Margin (TTM)N/A24.34%N/A
Return on Equity40.16%15.08%Oxygenta
Return on Assets (TTM)-12.44%11.87%Sun Pharmaceutical
Free Cash Flow (TTM)$-87.89M$119.44BSun Pharmaceutical
Dividend YieldN/A1.26%N/A
1-Year Return99.93%-7.63%Oxygenta
Price-to-Sales Ratio (TTM)2.697.29Oxygenta
Enterprise Value$3.70B$3,667.83BSun Pharmaceutical
EV/Revenue Ratio3.316.82Oxygenta
Gross Profit Margin (TTM)4.52%79.58%Sun Pharmaceutical
Revenue per Share (TTM)$31$224Sun Pharmaceutical
Earnings per Share (Diluted)$-2.86$43.27Sun Pharmaceutical
Beta (Stock Volatility)0.560.31Sun Pharmaceutical
Performance
Key Stats
Valuation
Financials
Short Interest
Dividends

Oxygenta vs Sun Pharmaceutical Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Oxygenta-0.12%-9.18%-27.15%-10.28%-0.25%-5.93%
Sun Pharmaceutical0.10%0.07%-2.94%-5.16%-0.08%-13.09%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Oxygenta99.93%193.27%211.39%211.39%211.39%211.39%
Sun Pharmaceutical-7.63%86.35%195.13%85.03%824.99%2,689.93%

Performance & Financial Health Analysis: Oxygenta vs Sun Pharmaceutical

MetricOXYGENTAPHSUNPHARMA
Market Information
Market Cap i₹3.01B₹3.92T
Market Cap CategorySmall capLarge cap
10 Day Avg. Volume i8,4802,090,629
90 Day Avg. Volume i4,8872,138,036
Last Close₹80.55₹1,641.80
52 Week Range₹35.80 - ₹133.50₹1,553.05 - ₹1,960.35
% from 52W High-39.66%-16.25%
All-Time High₹133.50 (Jun 09, 2025)₹1,960.35 (Sep 30, 2024)
% from All-Time High-39.66%-16.25%
Growth Metrics
Quarterly Revenue Growth0.20%0.10%
Quarterly Earnings Growth3.69%-0.20%
Financial Health
Profit Margin (TTM) i-0.13%0.19%
Operating Margin (TTM) i-0.51%0.24%
Return on Equity (TTM) i0.40%0.15%
Debt to Equity (MRQ) i-2.433.26
Cash & Liquidity
Book Value per Share (MRQ)₹-7.15₹300.99
Cash per Share (MRQ)₹0.03₹108.88
Operating Cash Flow (TTM) i₹-89,042,000₹110.84B
Levered Free Cash Flow (TTM) i₹-102,983,000₹109.29B
Dividends
Last 12-Month Dividend Yield iN/A1.26%
Last 12-Month Dividend iN/A₹21.00

Valuation & Enterprise Metrics Analysis: Oxygenta vs Sun Pharmaceutical

MetricOXYGENTAPHSUNPHARMA
Price Ratios
P/E Ratio (TTM) i444.3237.74
Forward P/E iN/A49.97
PEG Ratio iN/A-1.94
Price to Sales (TTM) i2.697.29
Price to Book (MRQ) iN/A5.43
Market Capitalization
Market Capitalization i₹3.01B₹3.92T
Enterprise Value i₹3.70B₹3.67T
Enterprise Value Metrics
Enterprise to Revenue i3.316.82
Enterprise to EBITDA i-28.1823.91
Risk & Other Metrics
Beta i0.560.31
Book Value per Share (MRQ) i₹-7.15₹300.99

Financial Statements Comparison: Oxygenta vs Sun Pharmaceutical

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)OXYGENTAPHSUNPHARMA
Revenue/Sales i₹494.67M₹137.86B
Cost of Goods Sold i₹472.30M₹28.15B
Gross Profit i₹22.37M₹109.71B
Research & Development iN/AN/A
Operating Income (EBIT) i₹-14.00M₹33.72B
EBITDA i₹-13.51M₹47.66B
Pre-Tax Income i₹-37.99M₹31.73B
Income Tax i₹-16.46M₹8.70B
Net Income (Profit) i₹-21.53M₹22.93B

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)OXYGENTAPHSUNPHARMA
Cash & Equivalents i₹17,000₹102.69B
Total Current Assets i₹309.43M₹526.24B
Total Current Liabilities i₹858.47M₹181.94B
Long-Term Debt i₹215.22M₹3.58B
Total Shareholders Equity i₹-256.41M₹724.86B
Retained Earnings iN/A₹578.62B
Property, Plant & Equipment i₹368.30M₹100.36B

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)OXYGENTAPHSUNPHARMA
Operating Cash Flow iN/AN/A
Capital Expenditures iN/AN/A
Free Cash Flow iN/AN/A
Debt Repayment iN/AN/A
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricOXYGENTAPHSUNPHARMA
Shares Short iN/AN/A
Short Ratio iN/AN/A
Short % of Float iN/AN/A
Average Daily Volume (10 Day) i8,4802,090,629
Average Daily Volume (90 Day) i4,8872,138,036
Shares Outstanding i36.98M2.40B
Float Shares i2.30M1.04B
% Held by Insiders i0.79%0.56%
% Held by Institutions i0.00%0.25%

Dividend Analysis & Yield Comparison: Oxygenta vs Sun Pharmaceutical

MetricOXYGENTAPHSUNPHARMA
Last 12-Month Dividend iN/A₹21.00
Last 12-Month Dividend Yield iN/A1.26%
3-Year Avg Annual Dividend iN/A₹14.67
3-Year Avg Dividend Yield iN/A0.46%
3-Year Total Dividends iN/A₹44.00
Ex-Dividend DateN/AJul 07, 2025